The Incidence of Hepatocellular Carcinoma after Balloon-Occluded Retrograde Transvenous Obliteration

Table 1

Comparison of patient characteristics between the two groups: group A, patients without history of HCC before B-RTO (N = 40) and group B, patients with history of treatment for HCC and diagnosed with no HCC appearance when B-RTO was performed (N = 31).

	Group A (N = 40)	Group B (N = 31)	value
Age, years	61.5 ± 1.50	70.1 ± 1.70	0.0003^*
Gender
Male	24	13
Female	16	18	0.131
Etiology
HCV	36	30
HBV	4	1	0.269
FIB4 index	9.19 ± 1.04	9.69 ± 1.18	0.751
Child-Pugh score	7.37 ± 0.19	7.16 ± 0.22	0.464
	1.22 ± 0.13	1.41 ± 0.13	0.313
	1.13 ± 0.07	1.48 ± 0.07	0.0007^*
Injected 5% EOI, mL	27.8 ± 2.01	23.9 ± 2.28	0.198

FIB4 index = age (years) × AST [IU/L]/(Plt [109/L] × (ALT [IU/L]) 1/2).
HCV: hepatitis C virus, HBV: hepatitis B virus, AFP: alpha-fetoprotein, DCP: des-gamma-carboxy prothrombin, and EOI: ethanolamine oleate-iopamidol mixture.
values less than 0.05 were considered significant.